Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (381)	2/17/2004 12:23:42 AM
From: richardred	Read Replies (2) \| Respond to of 7259

I think Merck will be looking at US generic assets. pb.merck.de Prgo looks to be buying the rest of Lannett biz.yahoo.com Sun now controls Caraco Pharmaceutical biz.yahoo.com BNT and SPPI still look attractive to me.

To: richardred who wrote (381)	4/19/2004 9:29:39 AM
From: richardred	Read Replies (2) \| Respond to of 7259

German Merck still wants generics Reuters UPDATE - German Merck not interested in Pfizer unit-source Monday April 19, 5:30 am ET By Sitaraman Shankar (Releads with industry source on Merck) FRANKFURT, April 19 (Reuters) - German drugmaker Merck (XETRA:MRCG.DE - News) is not interested in buying U.S. giant Pfizer's Heumann unit or any other firm focussing on Germany, an industry source said on Monday after Heumann said the two had talked. Merck said in February it would look to buy generics companies and licences for prescription drugs after selling its U.S. lab distribution business for $1.68 billion, and sources told Reuters last week it was in due diligence with some firms.